Table 3. Results of univariate and multivariate analyses.

Covariate			OS				DFS
			Univariate		Multivariate		Univariate		Multivariate
			HR (CI 95%)	P-value	HR (CI 95%)	P-value	HR (CI 95%)	P-value	HR (CI 95%)		P-value
Age			0.98(0.94–1.02)	0.35			1.00(0.97–1.03)	0.84
Size			1.19(1.15–1.45)	0.07	1.00(0.78–1.28)	0.98	1.15(0.98–1.34)	0.09	0.94(0.77–1.15)		0.54
Grade (3 over 1 or 2)			3.66(1.44–9.29)	0.01	2.93(0.91–9.46)	0.07	2.57(1.18–5.58)	0.02	2.61(0.97–7.00)		0.06
Stage	2		0.73(0.14–3.74)	0.70	0.40(0.07–2.37)	0.32	0.39(0.11–1.38)	0.14	0.23(0.06–0.90)		0.03
	3		3.26(0.73–14.63)	0.12	2.22(0.36–13.63)	0.39	2.81(0.97–8.20)	0.06	2.11(0.56–8.00)		0.27
ER or PR(Positive over Negative)			0.33(0.13–0.82)	0.02	0.42(0.15–1.18)	0.10	0.42(0.21–0.85)	0.02	0.48(0.20–1.14)		0.10
HER2/neu(Positive over Negative)			1.54(0.58–4.06)	0.38			1.57(0.74–3.34)	0.24
P53			4.22(1.60–11.11)	0.00	5.04(1.71–14.94)	0.003	2.74(1.34–5.60)	0.01	3.81(1.68–8.64)		0.001
Menopause (menopause over pre-menopause)			0.96(0.37–2.54)	0.94			1.15(0.55–2.40)	0.70